AvertD Post-Approval Study

NCT07135323 · clinicaltrials.gov ↗

RECRUITING

Status

4000

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid Use Disorder

Interventions

GENETIC: Opioid Used Disorder Risk Assessment

Sponsor

Prescient Medicine Holdings, Inc.

Collaborators

[object Object]
[object Object]